A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/09/2002	EP1246637A2 Methods of modulation of the immune system
10/09/2002	EP1246636A2 Molecules that influence pathogen resistance
10/09/2002	EP1246634A1 Methods for treating pancreatic disorders
10/09/2002	EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002	EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002	EP1246609A2 Micronized freeze-dried particles
10/09/2002	EP1246608A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
10/09/2002	EP1009411A4 Method and composition for treating sleep apnea
10/09/2002	EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002	EP0967986B1 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
10/09/2002	EP0880360B1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
10/09/2002	EP0868434B1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/09/2002	EP0838473B1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/09/2002	EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
10/09/2002	EP0825863B1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/09/2002	EP0804562B1 Connective tissue growth factor-2
10/09/2002	EP0783521B1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/09/2002	EP0772590B1 Thrombin inhibitors
10/09/2002	EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
10/09/2002	EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002	EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder
10/09/2002	EP0693934B1 Methods and compositions for the prevention or treatment of sexually transmitted diseases
10/09/2002	CN1373808A Calpains and their use
10/09/2002	CN1373805A Antigenic meningococcal peptides
10/09/2002	CN1373804A Conditional immortalisation of cells
10/09/2002	CN1373801A Glucuronoxylomannan (GXM)-O-acetylhydrolase of cryptococcus neoformans and uses thereof
10/09/2002	CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002	CN1373773A Polynucleotides encoding human angiotensin-II-1 receptor proteins and method of preparation and its use
10/09/2002	CN1373772A Gene encoding human huntingtin interacting polypeptide which comprises WW domain and its producing method and application
10/09/2002	CN1373770A Pseudomycin prodrugs
10/09/2002	CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002	CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002	CN1373671A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies
10/09/2002	CN1373670A Tissue volume reduction
10/09/2002	CN1373669A Hybrid polypeptides with enhanced pharmacokinetic properties
10/09/2002	CN1373668A Hybrid peptide modulate immune response
10/09/2002	CN1373657A Method for controlled production of ultrafine microparticles and nanoparticles
10/09/2002	CN1373217A Cell multiplication factor Fwap10576
10/09/2002	CN1373216A Muscle cell multiplication suppressor factor Fwa267
10/09/2002	CN1373211A Human G-type lysozyme and its coding sequence, preparing process and application
10/09/2002	CN1373139A Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof
10/09/2002	CN1372974A Exterior-applied gel contaiing lysozyme as primary component and its preparing process
10/09/2002	CN1372973A Powder snuff of insulin for administration of lung and its preparing process
10/08/2002	WO2001080874A1 Bone-strengthening agents, food compositions for strengthening bone and feed compositions for strengthening bone
10/08/2002	USRE37872 Enzymes
10/08/2002	US6463335 Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
10/08/2002	US6462177 Mammalian blood loss-induced gene, kd312
10/08/2002	US6462174 Amorphous compound
10/08/2002	US6462173 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
10/08/2002	US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment
10/08/2002	US6462170 UPAR mimicking peptide
10/08/2002	US6462070 Photosensitizer conjugates for pathogen targeting
10/08/2002	US6462067 Administering histamine or salt derivative; preventing and/or reducing oxidative cellular and tissue damage; inflammatory diseases, including rheumatoid arthritis, crohn's disease, and adult respiratory distress syndrome
10/08/2002	US6462050 For treating or preventing venous, cardiogenic, and arterial thrombosis/embolism, athersclerosis, and for lowering propensity of devices that come into contact with blood to clot blood
10/08/2002	US6462022 Lisinopril compositions having large-particle DCPD
10/08/2002	US6462021 Melagatran or derivative; nonvalvular atrial fibrillation; thrombotic or ischemic stroke, transient ischemic attack or systemic embolism
10/08/2002	US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis
10/08/2002	US6462019 Inhibitors of proteasomal activity and production for stimulating bone growth
10/08/2002	US6462017 Method of reducing side effects of chemotherapy in cancer patients
10/08/2002	US6462016 Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method
10/08/2002	US6461867 Synthetic antigen presenting matrix
10/08/2002	US6461851 High expression modules containing two or more tandem copies of a methioninase encoding sequence
10/08/2002	US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques
10/08/2002	US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
10/08/2002	US6461826 Essential fungal genes and their use
10/08/2002	US6461824 Production of chimeric antibodies with specificity to human tumor antigens
10/08/2002	US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002	US6461821 Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
10/08/2002	US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide
10/08/2002	US6461642 Crystallization using supercritical or subcritical fluids
10/08/2002	US6461640 Local delivery of fibrinolysis enhancing agents
10/08/2002	US6461628 Non-woven keratin cell scaffold
10/08/2002	US6461618 Immunizing human host against moraxella catarrhalis by administering immunogenic amount of vaccine composition comprising isolated and purified 74 kd protein of moraxella catarrhalis having specified amino acid sequence
10/08/2002	US6461617 Recombinant toxin fragments
10/08/2002	US6461615 Therapeutic and prophylactic methods using heat shock proteins
10/08/2002	US6461614 Fibronectin binding proteins
10/08/2002	US6461613 Methods and compositions for the selective regulation of chorionic prostanoids
10/08/2002	US6461612 Genetic engineering
10/08/2002	US6461611 Agents for the prevention of damages caused by stress conditions
10/08/2002	US6461610 Methods for modifying cell motility using factor VIIa or inactivated factor VIIa
10/08/2002	US6461609 Recombinant α-galactosidase a therapy for Fabry disease
10/08/2002	US6461606 Materials and methods for gene therapy
10/08/2002	US6461605 Continuous low-dose cytokine infusion therapy
10/08/2002	US6461593 Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
10/08/2002	US6461331 Preferably, the medication delivery device is an infusion pump.
10/08/2002	CA2254145C Improved process to stabilize proteins
10/08/2002	CA2231046C Human protein kinases hyak3
10/08/2002	CA2218074C Powdered pharmaceutical formulations having improved dispersibility
10/08/2002	CA2182486C Cyclic neurokinin a antagonists
10/08/2002	CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/08/2002	CA2126680C Novel megakaryocyte potentiator
10/08/2002	CA2047119C Vitro processing of fusion proteins
10/06/2002	CA2378565A1 Crystal structure
10/03/2002	WO2002077294A1 Peroxiredoxin drugs for treatment of hiv-1 infection and methods of use thereof
10/03/2002	WO2002077290A1 Methods for modifying pharmacokinetics and bioavailability of exogenous compounds
10/03/2002	WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002	WO2002077260A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/03/2002	WO2002077257A1 Novel nucleic acids and polypeptides
10/03/2002	WO2002077243A1 Diagnosis of cancer or benign tumour using the aberrant expression product of the klk4 gene
10/03/2002	WO2002077236A2 Compositions and methods relating to lung specific genes and proteins

1 ... 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 ... 3163